Feedback / Questions
berubicin (RTA 744) - CNS Pharma, WPD Pharma
http://www.globenewswire.com/news-release/2020/04/24/2021500/0/en/WPD-Pharmaceuticals-Announces-FDA-Application-Under-The-Orphan-Drug-Act-Was-Submitted-By-License-Partner-for-Brain-Cancer-Drug-Berubicin.html
Apr 24, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next